Loading…
Tuesday, May 12
 

8:00am EDT

Registration Opens & Continental Breakfast for Attendees
Tuesday May 12, 2026 8:00am - 9:00am EDT
Tuesday May 12, 2026 8:00am - 9:00am EDT

8:55am EDT

Welcome and Chairperson’s Introduction & Opening Remarks
Tuesday May 12, 2026 8:55am - 9:00am EDT
Speakers
avatar for Firouz Asgarzadeh, PhD

Firouz Asgarzadeh, PhD

President of Consulting Services, OSD Pharmaceutical Solutions
Firouz Asgarzadeh, Ph.D. is founder of OSD Pharmaceutical Solutions LLC (an independent consulting firm) which provides formulation and process development services to pharmaceutical companies. Dr. Asgarzadeh has over 29+ years of global R&D and commercial experience in leadership... Read More →
Tuesday May 12, 2026 8:55am - 9:00am EDT

9:00am EDT

From Formulation to Function: Engineering Drug Product Quality to Maximize Therapeutic Performance
Tuesday May 12, 2026 9:00am - 9:40am EDT
For drug product scientists and formulators, the ultimate measure of success lies not just in developing a stable formulation, but in ensuring that a drug product consistently delivers its intended therapeutic effect. In this keynote, Mansoor Khan will explore how a deeper scientific understanding of drug product quality—through critical quality attributes (CQAs), advanced analytical...
See More →
Speakers
avatar for Mansoor Khan, PhD

Mansoor Khan, PhD

Dean & Distinguished Professor of Pharmaceutical Sciences & Ex CDER FDA, Texas A&M University
Tuesday May 12, 2026 9:00am - 9:40am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

9:40am EDT

Amorphous Solid Dispersions and Crystallinity
Tuesday May 12, 2026 9:40am - 10:10am EDT
The presentation will cover the industrial perspectivefor managing risk of crystallinity in amorphous soliddispersions, covering three key areas:• Manufacturability• Stability• BioavailabilityLearning Objectives• Norm on basics of solid dispersions• Establish understanding of failure modes for soliddispersion based on manufacturing technology• Develop appreciation for...
See More →
Speakers
avatar for Jim Di Nunzio, PhD

Jim Di Nunzio, PhD

Distinguished Scientist, Oral Solid Dosage Drug Product Development, Merck & Co.
Dr. James DiNunzio has over 12 years of oral solid dosage drug product development experience and currently serves as an Associate Principal Scientist at Merck & Co. Dr. DiNunzio received his Ph.D. in Pharmacy (Pharmaceutics track) from The University of Texas at Austin, and holds... Read More →
Tuesday May 12, 2026 9:40am - 10:10am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

10:10am EDT

Innovating Oral Drug Delivery: Enabling Small and Macromolecule Therapies
Tuesday May 12, 2026 10:10am - 10:40am EDT
The oral administration of macromolecules such as peptides and proteins continues to be limited by harsh gastrointestinal conditions, rapid enzymatic degradation, and poor membrane permeability. Novel delivery technologies—such as sophisticated lipid-based systems, delayed-release softgel platforms, and buccal or sublingual approaches—are emerging to overcome these barriers. By protecting...
See More →
Speakers
avatar for Karunakar (Karu) Sukuru, PhD

Karunakar (Karu) Sukuru, PhD

Global Vice President, Pharma Product Development & Head of Scientific Advisory, Catalent
Karunakar Sukuru is a distinguished leader in the pharmaceutical industry, with over three decades of expertise in Drug Product and Technology Development. At Catalent, he oversees the development of small molecule Rx products, guiding a team of over 800 scientists across 14 sites... Read More →
Tuesday May 12, 2026 10:10am - 10:40am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

10:40am EDT

Morning Networking Break in Exhibit Hall
Tuesday May 12, 2026 10:40am - 11:10am EDT
Tuesday May 12, 2026 10:40am - 11:10am EDT

11:10am EDT

Breaking the Dose Barrier for Subcutaneous Drug Delivery: Advancing High-Concentration Biologics Through Smart Device Design and Patient-Centered Innovation
Tuesday May 12, 2026 11:10am - 11:40am EDT
Amorphous solid dispersions (ASDs) are supersaturating formulations that enhance both theHigh-dose biologic drug products have become increasingly prevalent for treating chronic diseases across diverse therapeutic areas, with subcutaneous (SC) self-administration emerging as the preferred delivery route driven by patient and healthcare provider demand. However, developing these products presents...
See More →
Speakers
avatar for Indrajit Ghosh, PhD

Indrajit Ghosh, PhD

Scientific Director, Biologics Product Development, Bristol Myers Squibb
Pharmaceutical Sciences, CMC, and Innovation Leader with 23 years of end-to-end drug product development across biologics and small molecules from preclinical research through commercial launch. Currently leading device-enabled subcutaneous delivery programs for high-dose biologics... Read More →
Tuesday May 12, 2026 11:10am - 11:40am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

11:40am EDT

Beyond Solubility - A New Pharmaceutical Classification Guiding Enabled Formulations in the Modern Molecular Landscape
Tuesday May 12, 2026 11:40am - 12:10pm EDT
Modern drug development faces a significant challenge as over 70% of new pharmaceutical compounds struggle with low solubility. A novel classification framework is introduced to improve the design of enabled formulations, specifically focusing on amorphous solid dispersions. This system moves past basic solubility issues to evaluate how and when to consider the impact of dissolution and diffusion...
See More →
Speakers
avatar for Erica Schlesinger, PhD

Erica Schlesinger, PhD

Vice President of Technical Development, Seran Biosciences
Sponsors
avatar for Seran Bioscience

Seran Bioscience

At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. Our science-driven approach utilizes predictive design tools, novel chemistry, analytical tools, enabling delivery technologies, and a thorough... Read More →
Tuesday May 12, 2026 11:40am - 12:10pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

12:10pm EDT

Lifecycle Management and Reformulation Opportunities for Peptides and Challenging Small Molecules
Tuesday May 12, 2026 12:10pm - 12:40pm EDT
As pharmaceutical pipelines increasingly yield complex APIs—including poorly permeable small molecules and peptides—first-generation drug products often fall short of the ideal Target Product Profile. Sub-optimal bioavailability, positive food effects, and reliance on parenteral administration present significant hurdles to patient compliance and market success.This presentation explores how...
See More →
Speakers
avatar for Nicholas DiFranco, MEM

Nicholas DiFranco, MEM

Senior Global Marketing Manager - Pharmaceuticals, Gattefossé
Nick DiFranco, MEM, is the Senior Marketing Manager at Gattefossé Pharmaceuticals USA. In this role, he isresponsible for developing and executing a strategy to grow our North American market presence.
Most recently, Nick was the Global Market Segment Manager for Oral Treatments at Lubrizol Life Science Health (LLS Health). In his role, Nick coordinates a multi-disciplinary team offering excipients and services for controlled release and solubility enhancement in oral solids and... Read More →
Sponsors
avatar for Gattefossé USA

Gattefossé USA

Since 1880, Gattefossé has developed and manufactured high-quality lipid excipients for human and animal health. Our oral excipients offer solubility/bioavailability enhancement, sustained release, lubrication, and taste-masking. We also provide solubilizers, penetration enhancers... Read More →
Tuesday May 12, 2026 12:10pm - 12:40pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

12:40pm EDT

Networking Lunch
Tuesday May 12, 2026 12:40pm - 1:40pm EDT
Tuesday May 12, 2026 12:40pm - 1:40pm EDT

1:40pm EDT

Combining Extended Release with Bioavailability Enhancement
Tuesday May 12, 2026 1:40pm - 2:10pm EDT
A growing proportion of modern small-molecule drug candidates are challenged by oral absorption limitations arising from poor solubility, poor permeability, or both. For compounds that also require prolonged exposure, formulation strategy becomes more complex, particularly when once-daily dosing is desirable for chronic therapy, patient convenience, adherence, or competitive product positioning....
See More →
Speakers
avatar for Michael Grass, PhD

Michael Grass, PhD

Head of Innovation, Bend BioScience
Tuesday May 12, 2026 1:40pm - 2:10pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

2:10pm EDT

Engineering Solubility: Modern Approaches in OSD Formulation
Tuesday May 12, 2026 2:10pm - 2:40pm EDT
Poor solubility continues to limit the performance of many oral drug candidates. This session explores how strategic formulation design in oral solid dosage (OSD) development can enhance solubility and drive better bioavailability outcomes. From enabling technologies to rational design principles, attendees will gain practical insights into approaches that improve drug performance while supporting...
See More →
Speakers
avatar for Kush Patel, PhD

Kush Patel, PhD

Research Fellow, Oral Product Development, Pfizer, Inc.

Tuesday May 12, 2026 2:10pm - 2:40pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

2:35pm EDT

Safe by Design: Benefit-Risk Assessment Based Pediatric Excipient Selection
Tuesday May 12, 2026 2:35pm - 2:50pm EDT
The dilemma to select appropriate excipients for paediatric products can be resolved by applying systematic benefit-risk assessment process, by using the newly developed “Paediatric Excipient Risk Assessment (PERA)” framework and tool which will be presented and demonstrated by case studies in this session. Attendees will gain insights into how to balance functionality with safety to support...
See More →
Speakers
avatar for Anjali Agrawal, PhD

Anjali Agrawal, PhD

Executive Director, Marketing Product Development Portfolio, Novo Nordisk
Tuesday May 12, 2026 2:35pm - 2:50pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

3:00pm EDT

Afternoon Networking Break in Exhibit Hall
Tuesday May 12, 2026 3:00pm - 3:30pm EDT
Tuesday May 12, 2026 3:00pm - 3:30pm EDT

3:30pm EDT

Right Platform, Right Time: A Decision Framework for Solubility Challenges
Tuesday May 12, 2026 3:30pm - 4:00pm EDT

Speakers
avatar for Imre Vitez

Imre Vitez

Pre-formulation Manager, Ardena
Imre is a preformulation scientist with experience in materials characterization and th physical properties evaluation of pharmaceuticals. He is responsible for managing the preformulation function at Ardena Somerset by supporting the hot melt extrusion, oral solids, spray dry, nano-milling... Read More →
Tuesday May 12, 2026 3:30pm - 4:00pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

4:00pm EDT

Precision PK by Design: KinetiSol™- Enabled BAE and Controlled Release
Tuesday May 12, 2026 4:00pm - 4:30pm EDT
Precisely controlling exposure is critical to maximizing efficacy and minimizing risk. This session explores how KinetiSol™-enabled bioavailability enhancement (BAE) and controlled-release (CR) design enable next-generation PK optimization. Learn how high-energy amorphous processing and formulation tuning can rapidly shape exposure profiles—improving absorption, extending duration, and...
See More →
Speakers
avatar for Dave Miller, PhD

Dave Miller, PhD

Chief Scientific Officer, AustinPx
Tuesday May 12, 2026 4:00pm - 4:30pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

4:30pm EDT

The Hidden Secrets of Designing a Robust Oral Controlled Release Formulation
Tuesday May 12, 2026 4:30pm - 5:00pm EDT
Designing robust oral controlled release formulations requires more than extending drug release—it demands a deep understanding of formulation, physiology, and performance variability. This session uncovers the often-overlooked factors that impact success, from material selection and release mechanisms to in vivo predictability and scalability. Gain practical insights into avoiding common...
See More →
Speakers
avatar for Ali Rajabi-Siahboomi, PhD

Ali Rajabi-Siahboomi, PhD

Advisory, Leadership & innovation, ALi Pharma Solutions, LLC
Tuesday May 12, 2026 4:30pm - 5:00pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

5:00pm EDT

Developing Drug Products for Oral Delivery of Challenging Molecules: Formulation Design and Biopharmaceutical Considerations
Tuesday May 12, 2026 5:00pm - 5:30pm EDT
Small molecules that belong to BCS II and IV classes pose developability challenges and require formulation strategies to enhance oral bioavailability. This talk will discuss various strategies to overcome this problem. 1) Amorphous solid dispersions (ASDs)- This section will focus on dissolution mechanism of ASDs and strategies (surfactants, pH modifiers) to increase drug load in ASD without...
See More →
Speakers
avatar for Anura Indulkar, PhD

Anura Indulkar, PhD

Principal Scientist, Oral Formulation Sciences, Merck & Co.
Anura Indulkar, PhD is an Associate Principal Scientist in the Oral Formulation Sciences organization at Merck & Co., Inc since Mar 2025. She received her PhD in Industrial and Physical Pharmacy from Purdue University in 2017. She earned her Master’s in Pharmaceutics from National... Read More →
Tuesday May 12, 2026 5:00pm - 5:30pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

5:30pm EDT

Chair’s Closing Remarks, Drinks Reception in Exhibit Hall and End of Day One
Tuesday May 12, 2026 5:30pm - 6:30pm EDT

Tuesday May 12, 2026 5:30pm - 6:30pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA
 
Wednesday, May 13
 

9:00am EDT

Chairperson’s Welcome & Opening Remarks
Wednesday May 13, 2026 9:00am - 9:05am EDT
Wednesday May 13, 2026 9:00am - 9:05am EDT

9:00am EDT

KEYNOTE: Cellular Nanoparticles: Design, Fabrication, and Biomedical Applications
Wednesday May 13, 2026 9:00am - 9:35am EDT
The pharmaceutical industry is undergoing a profound transformation, shifting from traditional batch processes to continuous manufacturing. This evolution is partly propelled by advances in Process Analytical Technology (PAT) and the foundational principles of Quality by Design (QbD). Transitioning to a SMART factory mode of operation, however, requires technological innovation, significant...
See More →
Speakers
avatar for Liangfang Zhang, PhD

Liangfang Zhang, PhD

Professor, Department of Chemical and Nano Engineering, University of California San Diego
Wednesday May 13, 2026 9:00am - 9:35am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

9:35am EDT

Eudracap®: Ready-to-Fill Capsules Enhance Functional Performance
Wednesday May 13, 2026 9:35am - 10:00am EDT
Eudracap® capsules leverage functional polymer technology to deliver enteric and site-specific release without additional coating steps. These systems enable robust performance, reduced process complexity, and improved scalability. This session will examine formulation considerations, performance data, and applications across modified release strategies.
Speakers
avatar for Brian Phillips, PhD

Brian Phillips, PhD

Principal Scientist, Evonik
Wednesday May 13, 2026 9:35am - 10:00am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

10:00am EDT

Room-Temperature Aerosol Dehydration: A Continuous, Scalable Platform for Thermostable Formulations of Biologics with Enhanced Delivery Performance
Wednesday May 13, 2026 10:00am - 10:25am EDT
Room-Temperature Aerosol Dehydration (RTAD) is an emerging continuous drug product formulation platform that converts liquid biologics and vaccines into shelf-stable, bioactive powders without cold chain dependency. Developed at Princeton University and commercialized by Inaedis, Inc., this scalable cGMP-compatible process gently generates aerosols of sub-20 µm droplets that flash-evaporate at...
See More →
Speakers
avatar for Maksim Mezhericher, PhD.

Maksim Mezhericher, PhD.

Founder and CEO, Inaedis, Inc.
Wednesday May 13, 2026 10:00am - 10:25am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

10:25am EDT

Lets Break this Down: Lipid Digestion & its Significance in in-vitro Permeation Models for Emulsion Systems
Wednesday May 13, 2026 10:25am - 10:50am EDT
Lipid-based emulsions are increasingly used to enhance drug delivery, yet the impact of lipid digestion on permeation outcomes is often overlooked. This session examines how enzymatic digestion transforms emulsions into dynamic colloidal structures—such as mixed micelles and vesicles—that directly influence drug solubilization and transport across biological barriers. We will discuss why...
See More →
Speakers
avatar for Shabbir Lobo, PhD

Shabbir Lobo, PhD

Staff Scientist, Global Innovations and Product Development, Bayer
Shabbir is a skilled formulator in Transdermals, Modified Release oral Dosages and Topicals for Abbreviated New Drug Application (ANDA) and 505 b2 submissions. Attuned to current FDA regulations for a QbD based product development. dFMEA through the development of dosage form and... Read More →
Wednesday May 13, 2026 10:25am - 10:50am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

10:50am EDT

Morning Networking Break in Exhibit Hall
Wednesday May 13, 2026 10:50am - 11:20am EDT

Wednesday May 13, 2026 10:50am - 11:20am EDT

11:20am EDT

Designing a Universal Nasal Drug Delivery Platform to Enhance Bioavailability of Challenging Small Molecules
Wednesday May 13, 2026 11:20am - 11:45am EDT
Nasal drug delivery is emerging as a powerful alternative for small molecules limited by poor bioavailability. This session explores the design of a universal nasal delivery platform engineered to overcome solubility, permeability, and stability challenges. Discover how smart formulation and device strategies can unlock rapid absorption, consistent exposure, and new therapeutic potential for...
See More →
Speakers
avatar for Deb Das, PhD

Deb Das, PhD

Senior Associate Director & Science Fellow, Research and Development, Bayer
Debanjan (Deb), is a drug delivery scientist and an innovation-driven technical manager with over 19 years of product development experience in driving projects from concept to commercialization. He has marketed more than 40 commercial products in US (small molecules & biologics... Read More →
Wednesday May 13, 2026 11:20am - 11:45am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

11:45am EDT

Amorphous Solid Dispersion Development for Straightforward to Challenging Compounds
Wednesday May 13, 2026 11:45am - 12:10pm EDT
This session explores practical strategies for ASD development and manufacturing across a spectrum of molecule complexity, from straightforward to highly challenging. Formulation, scale-up, and manufacturing approaches will be discussed with case studies for a range of selected compounds. A case study including development of an extended release tablet for an ASD intermediate will...
See More →
Speakers
avatar for Corey Bloom, PhD

Corey Bloom, PhD

Principal Product Development Lead, Lonza
Wednesday May 13, 2026 11:45am - 12:10pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

12:10pm EDT

Overview of the Current Landscape of Long Acting Injectable (LAI) Drug Product Development
Wednesday May 13, 2026 12:10pm - 12:35pm EDT
Long acting injectables offer a powerful approach to improve patient care and reduce global healthcare costs through reduced dose frequency and better medication adherence.  However, LAI product design requires a deep understanding of chemistry, manufacturing, and controls (CMC) aspects, including material properties, formulation, processing, and device characteristics. This session will...
See More →
Speakers
avatar for Andrew Leithead , PhD

Andrew Leithead , PhD

Associate Principal Scientist, Discovery Pharmaceutical Sciences, Merck Research Laboratories
Wednesday May 13, 2026 12:10pm - 12:35pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

12:35pm EDT

The Severed Loop: We Are Formulating for Patients We Have Never Met
Wednesday May 13, 2026 12:35pm - 1:00pm EDT

Speakers
avatar for Neha Raje, PhD

Neha Raje, PhD

Founder, Oneness
Wednesday May 13, 2026 12:35pm - 1:00pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

1:00pm EDT

Networking Lunch
Wednesday May 13, 2026 1:00pm - 2:00pm EDT

Wednesday May 13, 2026 1:00pm - 2:00pm EDT

2:00pm EDT

Assessing the Facts Concerning Excipient Safety and Misinformation: From Nitrosamines to Talc, Titanium Dioxide and Colorants
Wednesday May 13, 2026 2:00pm - 2:25pm EDT
Excipient safety has become a growing focus for regulators, industry, and the public, particularly around topics such as nitrosamines, talc, titanium dioxide, and pharmaceutical colorants. This session will review the current scientific evidence and regulatory perspectives surrounding these widely discussed materials. By separating data-driven risk assessments from common misconceptions, the...
See More →
Speakers
avatar for David Schoneker, PhD

David Schoneker, PhD

President, Black Diamond Regulatory Consulting, LLC

Wednesday May 13, 2026 2:00pm - 2:25pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

2:25pm EDT

Physiologically Based Biopharmaceutics Modeling (PBBM) Applications in Drug Development
Wednesday May 13, 2026 2:25pm - 2:50pm EDT
PBBM and PBPK modeling are increasingly central to mechanistic understanding of drug absorption and systemic exposure. By linking critical material attributes, process parameters, and physiological variables, these approaches enable quantitative prediction of in vivo performance, virtual bioequivalence, and biowaiver strategies. This session will highlight recent advances in model-informed drug...
See More →
Speakers
avatar for Nicole Jarvi, PhD

Nicole Jarvi, PhD

Senior Scientist, Biologics & Biopharmaceutics Sterile Product Development, Merck
Wednesday May 13, 2026 2:25pm - 2:50pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

2:50pm EDT

Afternoon Networking Break in Exhibit Hall
Wednesday May 13, 2026 2:50pm - 3:10pm EDT

Wednesday May 13, 2026 2:50pm - 3:10pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

3:10pm EDT

Optimizing Regional and Systemic Pharmacokinetics with Lipid-based Drug Products
Wednesday May 13, 2026 3:10pm - 3:35pm EDT
Lipid nanoparticles (LNPs) have emerged as a transformative platform for drug delivery, yet optimizing their design remains complex. This session will explore how formulation strategies, lipid selection, and process parameters can be fine-tuned to improve stability, targeting, and delivery efficiency. Attendees will gain practical insights into overcoming key development challenges and unlocking...
See More →
Speakers
avatar for Vivek Gupta, PhD

Vivek Gupta, PhD

Associate Professor, Pharmaceutical Sciences, St. John’s University
Wednesday May 13, 2026 3:10pm - 3:35pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

3:35pm EDT

Agglomerated Crystalline Sodium Caprate: Enabling Better Tablet Performance
Wednesday May 13, 2026 3:35pm - 4:10pm EDT
Overcoming the Challenge of Processing Permeation Enhancers into Robust Drug Product.
Speakers
avatar for Andrew Parker, PhD

Andrew Parker, PhD

Principal Scientist, Oral Formulation Sciences, Merck & Co.
Wednesday May 13, 2026 3:35pm - 4:10pm EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

4:10pm EDT

Chair’s Closing Remarks and End of Day Two
Wednesday May 13, 2026 4:10pm - 4:15pm EDT

Speakers
avatar for Firouz Asgarzadeh, PhD

Firouz Asgarzadeh, PhD

President of Consulting Services, OSD Pharmaceutical Solutions
Firouz Asgarzadeh, Ph.D. is founder of OSD Pharmaceutical Solutions LLC (an independent consulting firm) which provides formulation and process development services to pharmaceutical companies. Dr. Asgarzadeh has over 29+ years of global R&D and commercial experience in leadership... Read More →
Wednesday May 13, 2026 4:10pm - 4:15pm EDT
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.